Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chunlin Zong has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Lei Tian

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology, The Fourth Military Medical University, Xi’an 710032, China

    9 shared publications
  • Chong Huang

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology, The Fourth Military Medical University, Xi’an 710032, China

    5 shared publications
  • Dandan Wang

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology, The Fourth Military Medical University, Xi’an 710032, China

    5 shared publications
  • Heng Li

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology, The Fourth Military Medical University, Xi’an 710032, China

    5 shared publications
  • Ting Mou

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology, The Fourth Military Medical University, Xi’an 710032, China

    5 shared publications
  • Zhiyue Zhang

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology, The Fourth Military Medical University, Xi’an 710032, China

    5 shared publications

Latest Publications

  • Open Access

    The outcome of digital technology in microvascular free flap reconstruction for ORNJ: a retrospective study

    by Xinyue Xu, Zihao Tang, Dandan Wang, Chenlu Li, Jihong Wang, Yiwen Liu, Lei Tian, Chunlin Zong

    Background: Osteoradionecrosis of the jaw (ORNJ) is a serious and refractory late complication of radiotherapy used in the treatment of head and neck cancer. Microvascular free flap reconstruction is an ideal option to reconstruct the residual defect after surgical resection of ORNJ lesion. The application of virtual surgical planning (VSP) and three-dimensional printing (3DP) can effectively improve the reconstructive results with free flaps in jaw bone defect. However, the effect of VSP and 3DP in ORNJ reconstruction with free flaps is still unclear. A retrospective study was conducted to evaluate the free flap types, the success rate, and complications in ORNJ. Methods: The ORNJ inpatients that underwent free flaps reconstruction in our hospital between 2012 and 2024 were included in the study and divided into the conventional flap (CF) and digital flap (DF) groups with the application of VSP and 3DP. The patient characteristics and microvascular free flap reconstruction outcome were reviewed. Results: A total of 35 ORNJ patients with 39 free flaps were included in the study. The success rate of free flaps reconstruction in ORNJ was 89.7%, with the postoperative early complication rate of 58.9% and late complication rate of 25.6%. Fibula was the most commonly used flap type (76.9%) of ORNJ defect reconstruction and had the lowest complication rate (63.3%). The success rate between the CF (92.9%) and DF (88%) groups had no significant difference. The mean surgical duration and the length of hospital stay in the DF group were significantly shorter than those of the CF group. Moreover, the difference of the postoperative complication rate between the CF (78.6%) and DF (64%) groups was not statistically significant. The fistula formation rate was significantly lower in the DF group than in the CF group. Conclusion: Microvascular free flap reconstruction is safe and effective for advanced osteoradionecrosis of the jaw, with the fibula flap representing the most favorable donor site. The adjunctive use of virtual surgical planning and three-dimensional printing significantly reduces the operative time, length of hospital stay, and fistula formation. These digital techniques are valuable adjuvant tools that optimize surgical efficiency and decrease critical complications in ORNJ reconstruction.

  • Open Access

    Correction: Li et al. Multifunctional Fe3O4@ZIF-8 Nanoparticles with Antibiosis and Osteogenesis for Treatment of Jaw Osteomyelitis. Pharmaceutics 2026, 18, 359

    by Heng Li, Zhiyue Zhang, Yu Wang, Ting Mou, Jiaqi Tian, Chong Huang, Lu Zhao, Zeyang Ge, Dandan Wang, Chenlu Li, et al.

  • Open Access

    Fe3O4 Magnetic Nanoparticles and Static Magnetic Field Stimulated BMSC-Derived Exosomes Promoted Osteogenesis and Alleviated Oxidative Stress in Irradiated BMSCs Through miR-429/NOG Pathway

    by Ting Mou, Chong Huang, Zhiyue Zhang, Heng Li, Lu Zhao, Yuxin Bing, Dandan Wang, Lei Tian, Chunlin Zong

    Radiation-induced bone injury, characterized by oxidative stress damage and impaired osteogenesis, lacks effective treatments. Exosome-based therapies have recently emerged as a safe and effective modality for radiation damage, and their functional capacity can be further potentiated through tailored preconditioning strategies—such as nanoparticle induction or physical stimulation. This study developed a novel exosome-based therapy by preconditioning bone marrow mesenchymal stem cells (BMSCs) with Iron oxide (Fe3O4) magnetic nanoparticles (MNPs, 50 µg/mL) and a static magnetic field (SMF, 100 mT). Exosomes derived from these preconditioned cells (BMSC-Fe3O4-SMF-Exos) exhibited enhanced yield and dual functionality. In irradiated BMSCs, BMSC-Fe3O4-SMF-Exos significantly promoted osteogenic differentiation, restoring alkaline phosphatase activity, mineralization, and expression of RUNX2, OCN, and COL1A1. They concurrently alleviated oxidative stress by scavenging reactive oxygen species, reducing malondialdehyde, and boosting superoxide dismutase activity. Mechanistically, miR-429 was found to be highly enriched in BMSC-Fe3O4-SMF-Exos, which directly targeted Noggin (NOG). Our functional validation experiments also confirmed that overexpression of miR-429 could inhibit NOG, alleviate oxidative stress and rescue the osteogenic differentiation of irradiated BMSCs. In conclusion, exosomes derived from preconditioning BMSCs with Fe3O4 MNPs and SMF mitigate radiation-induced damage via the miR-429/NOG pathway, presenting a promising cell-free strategy for bone regeneration.


  • Open Access

    Multifunctional Fe3O4@ZIF-8 Nanoparticles with Antibiosis and Osteogenesis for Treatment of Jaw Osteomyelitis

    by Heng Li, Zhiyue Zhang, Yu Wang, Ting Mou, Jiaqi Tian, Chong Huang, Lu Zhao, Zeyang Ge, Dandan Wang, Chenlu Li, et al.

    Background/Objectives: Jaw osteomyelitis (OM) is a refractory purulent inflammation caused by bacterial infection, characterized by persistent infection, excessive bone resorption, and resultant bone defects. Currently, mainstream therapies for jaw OM struggle to eradicate persistent infections, avoid antibiotic resistance, and repair infected bone defects, posing a critical challenge in clinical practice. Methods: Herein, the Fe3O4@ZIF-8 core–shell nanoparticles (NPs) platform designed for jaw OM treatment consisted of Fe3O4 as the core and zeolitic imidazolate framework-8 (ZIF-8) as the shell. Results: The core–shell platform not only integrated the pH-responsive degradation capability of ZIF-8 but also retained the superparamagnetism of Fe3O4 NPs. In the acidic, infectious microenvironment, Fe3O4@ZIF-8 NPs underwent continuous degradation, releasing Zn2+, thereby conferring potent antibacterial activity. The specific antibacterial mechanism of the nanoparticles lies in the fact that high concentrations of Zn2+ directly disrupted bacterial cell membranes and inhibited the bacterial heat shock response. This dysregulates bacterial proteostasis, rendering the bacteria more sensitive to external adverse stresses, ultimately leading to bacterial death. With ZIF-8 framework degradation, the encapsulated Fe3O4 NPs were released. Under static magnetic field (SMF) synergy, Fe3O4 NPs collaborated with Zn2+ to promote bone regeneration and repair infected bone defects in jaw OM lesions. Conclusions: As a multifunctional core–shell platform, Fe3O4@ZIF-8 NPs meet the dual clinical needs of antibiosis and osteogenesis, offering a promising translational strategy for jaw OM therapy.


  • Open Access

    Exosomes Derived from BMSCs Treated with CeONPs Ameliorate Radiation-Induced Jaw Bone Injury via miR-21-5p/STAT3 Axis-Mediated Osteogenesis and ROS Scavenging

    by Zhiyue Zhang, Heng Li, Chong Huang, Ting Mou, Jiaqi Tian, Zeyang Ge, Lu Zhao, Dandan Wang, Chenlu Li, Taiqiang Dai, et al.

    Background/Objectives: Radiation-induced jaw bone injury is a severe and refractory complication following radiotherapy, and the key to treatment is promoting osteogenic differentiation and alleviating oxidative stress injury in irradiated BMSCs. Cerium oxide nanoparticles (CeONPs) exhibit considerable research potential in various oxidative stress injury-related diseases due to their excellent reactive oxygen species (ROS) scavenging capacity; however, its biosafety risk makes direct application in disease treatment a matter of controversy. Methods: Recent evidence suggests that treating cells with nanoparticles can regulate the content of exosomes, enhancing the regenerative potential of exosomes. Accordingly, this study was designed to explore the therapeutic effects and underlying mechanism of exosomes derived from BMSCs treated with CeONPs (BMSC-Ce-exos) in radiation-induced jaw bone injury. Results: In vitro, 25 μg/mL CeONPs were identified as the optimal treatment concentration; BMSC-Ce-exos significantly promoted the osteogenic differentiation and reduced the ROS levels of irradiated BMSCs. In vivo, BMSC-Ce-exos notably promoted bone formation and decreased the ROS levels in rats with radiation-induced jaw bone injury. miRNA sequencing revealed that BMSC-Ce-exos were highly enriched with miR-21-5p, which promoted the osteogenic differentiation and reduced the ROS levels of irradiated BMSCs through targeting STAT3. Conclusions: Collectively, these results suggest that BMSC-Ce-exos provided a potential therapeutic approach for radiation-induced jaw bone injury.

  • Open Access

    From Mechanism to Therapy: The Role of MSC-EVs in Alleviating Radiation-Induced Injuries

    by Chong Huang, Heng Li, Zhiyue Zhang, Ting Mou, Dandan Wang, Chenlu Li, Lei Tian, Chunlin Zong

    Radiation injury is a severe issue in both nuclear accidents and cancer radiotherapy. Ionizing radiation impairs the regenerative and repair capabilities of tissues and organs, resulting in a scarcity of effective therapeutic approaches to prevent or mitigate such injuries. Mesenchymal stem cells (MSCs) possess favorable biological characteristics and have emerged as ideal candidates for the treatment of radiation injury. However, the use of MSCs as therapeutic agents is associated with uncertainties in therapeutic efficacy, transient effects, and the risk of immune rejection. Recent advances in research have revealed that extracellular vesicles (EVs) derived from mesenchymal stem cells (MSC-EVs) exhibit similar beneficial properties to MSCs and represent a promising cell-free therapy for mitigating radiation injuries. MSC-EVs are enriched with microRNAs (miRNAs), proteins, and lipids, which can modulate immune responses, inflammatory reactions, cell survival, and proliferation in irradiated tissues. This review synthesizes recent studies on the application of MSC-EVs in radiation injury, focusing on the therapeutic effects and mechanisms of MSC-EVs derived from various sources in radiation-induced diseases of different organs. The therapeutic potential of MSC-EVs for radiation injury provides valuable insights for addressing ionizing radiation-induced injuries and offers a reference for future clinical applications.


  • Open Access

    Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw

    by Han-Jin Ruan, Heng Chen, Jin-Song Hou, Jin-Gang An, Yu-Xing Guo, Bing Liu, Lei Tian, Jian Pan, Jin-Song Li, Can-Hua Jiang, et al.


  • Open Access

    Treatment effects of 3D-printed PCL/Fe3O4@ ZIF-8 magnetic nanocomposite on infected bone defect

    by Yun Xiao, Yi Ding, Jun Qiu, Xiaonan Zhang, Yanzhen Zheng, Chong Huang, Lu Zhao, Zihao Tang, Yuanli Chen, Yiwen Liu, et al.

    Treatment of large bone defects remains a clinical challenge, especially for defects compounded by infection. It is essential to develop dual functional therapeutic systems that inhibit bacterial growth and promote bone regeneration for infected bone defects treatment. However, the ideal bone substitute biomaterials to repair infected bone defects remain scarce. In this study, we fabricated a novel magnetic nanocomposite with polycaprolactone (PCL)/Fe3O4@zinc-based imidazole zeolite framework-8 (ZIF-8) through three-dimensional (3D) printing technology. The biomaterial characterization, biocompatibility, antibacterial activity, and osteogenic ability of the 3D-printed PCL/Fe3O4@ZIF-8 nanocomposite were systematically investigated in vivo and in vitro. The 3D-printed PCL/Fe3O4@ZIF-8 nanocomposite scaffolds showed a square porous grid structure with rough surface, thermal stability, superparamagnetic character, and slow release of Zn2+. The elevation of Fe3O4@ZIF-8 concentration increased surface roughness and porosity, improved the mechanical properties, and enhanced the saturation magnetization of PCL/Fe3O4@ZIF-8 scaffolds. The PCL/Fe3O4@ZIF-8 scaffolds possessed good biocompatibility and promoted the proliferation and adhesion of rat bone marrow mesenchymal stem cells (BMSCs). The PCL/Fe3O4@ZIF-8 scaffolds also upregulated the expression of osteogenic-related genes and proteins and promoted the osteogenic differentiation of BMSCs by activating the Wnt/β-catenin signaling pathway. Furthermore, the scaffolds showed excellent antibacterial activities, which increased with increasing Fe3O4@ ZIF-8 nanoparticle concentration. In vivo experiments proved that the scaffolds eliminated infection and promoted new bone formation in infected bone defect. Given excellent osteogenic and antibacterial activities, the 3D-printed PCL/Fe3O4@ZIF-8 nanocomposite scaffolds could serve as novel materials for the treatment of infected bone defects.


  • M2 macrophage-derived exosomes carry miR-142-3p to restore the differentiation balance of irradiated BMMSCs by targeting TGF-β1

    by Chong Huang, Lu Zhao, Yun Xiao, Zihao Tang, Li Jing, Kai Guo, Lei Tian, Chunlin Zong

    Radiotherapy is essential to cancer treatment, while it inevitably injures surrounding normal tissues, and bone tissue is one of the most common sites prone to irradiation. Bone marrow mesenchymal stem cells (BMMSCs) are sensitive to irradiation and the irradiated dysfunction of BMMSCs may be closely related to irradiation-induced bone damage. Macropahges play important role in regulating stem cell function, bone metabolic balance and irradiation response, but the effects of macrophages on irradiated BMMSCs are still unclear. This study aimed to investigate the role of macrophages and macrophage-derived exosomes in restoring irradiated BMMSCs function. The effects of macrophage conditioned medium (CM) and macrophage-derived exosomes on osteogenic and fibrogenic differentiation capacities of irradiated BMMSCs were detected. The key microribonucleic acids (miRNAs) and targeted proteins in exosomes were also determined. The results showed that irradiation significantly inhibited the proliferation of BMMSCs, and caused differentiation imbalance of BMMSCs, with decreased osteogenic differentiation and increased fibrogenic differentiation. M2 macrophage-derived exosomes (M2D-exos) inhibited the fibrogenic differentiation and promoted the osteogenic differentiation of irradiated BMMSCs. We identified that miR-142-3p was significantly overexpressed in M2D-exos and irradiated BMMSCs treated with M2D-exos. After inhibition of miR-142-3p in M2 macrophage, the effects of M2D-exos on irradiated BMMSCs differentiation were eliminated. Furthermore, transforming growth factor beta 1 (TGF-β1), as a direct target of miR-142-3p, was significantly decreased in irradiated BMMSCs treated with M2D-exos. This study indicated that M2D-exos could carry miR-142-3p to restore the differentiation balance of irradiated BMMSCs by targeting TGF-β1. These findings pave a new way for promising and cell-free method to treat irradiation-induced bone damage.


  • Open Access

    Addition of Adipose-Derived Stem Cells to Mesenchymal Stem Cell Sheets Improves Bone Formation at an Ectopic Site

    by Zhifa Wang, Zhijin Li, Taiqiang Dai, Chunlin Zong, Yanpu Liu, Bin Liu

    To determine the effect of adipose-derived stem cells (ADSCs) added to bone marrow-derived mesenchymal stem cell (MSC) sheets on bone formation at an ectopic site. We isolated MSCs and ADSCs from the same rabbits. We then prepared MSC sheets for implantation with or without ADSCs subcutaneously in the backs of severe combined immunodeficiency (SCID) mice. We assessed bone formation at eight weeks after implantation by micro-computed tomography and histological analysis. In osteogenic medium, MSCs grew to form multilayer sheets containing many calcium nodules. MSC sheets without ADSCs formed bone-like tissue; although neo-bone and cartilage-like tissues were sparse and unevenly distributed by eight weeks after implantation. In comparison, MSC sheets with ADSCs promoted better bone regeneration as evidenced by the greater density of bone, increased mineral deposition, obvious formation of blood vessels, large number of interconnected ossified trabeculae and woven bone structures, and greater bone volume/total volume within the composite constructs. Our results indicate that although sheets of only MSCs have the potential to form tissue engineered bone at an ectopic site, the addition of ADSCs can significantly increase the osteogenic potential of MSC sheets. Thus, the combination of MSC sheets with ADSCs may be regarded as a promising therapeutic strategy to stimulate bone regeneration.